Stuttgart - Delayed Quote EUR
Biomark Diagnostics Inc (20B.SG)
0.1640
+0.0080
+(5.13%)
At close: May 12 at 9:47:54 PM GMT+2
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
1,088.9200
732.2920
1,471.6200
952.9390
Total Liabilities Net Minority Interest
1,698.5260
1,881.8670
2,107.3120
1,032.0330
Total Equity Gross Minority Interest
-609.6060
-1,149.5750
-635.6920
-79.0940
Total Capitalization
-609.6060
-1,149.5750
-539.3890
12.5130
Common Stock Equity
-609.6060
-1,149.5750
-635.6920
-79.0940
Capital Lease Obligations
805.9310
498.5180
809.0440
27.7170
Net Tangible Assets
-609.6060
-1,149.5750
-635.6920
-79.0940
Working Capital
-1,044.5940
-1,538.1900
-1,002.2850
0.5920
Invested Capital
-609.6060
-824.2220
-395.3390
12.5130
Tangible Book Value
-609.6060
-1,149.5750
-635.6920
-79.0940
Total Debt
805.9310
823.8710
1,049.3970
119.3240
Net Debt
--
253.3160
--
--
Share Issued
90,886.2290
83,286.2290
77,974.2290
76,784.2290
Ordinary Shares Number
90,886.2290
83,286.2290
77,974.2290
76,784.2290
3/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade